Featured Article: Silent plight

May 22, 2024

Silent plight

Our Medical Director Tim Jobson was recently featured in Pharma Times talking about why a new approach is needed for primary biliary cholangitis trials.

Read the full article here: https://pharmatimes.com/web_exclusives/silent-plight/

In Practice with Dr. Denver: How does case-finding address unmet needs in Primary Biliary Cholangitis?

What is case finding? Case-finding is a data-driven approach to identifying individuals within a population who may be at high risk for developing a certain

The problem with liver trial bias, and how smart design can improve access.

Every new therapy relies on years of painstaking research, but what if that research overlooks the very people most in need? The problem: a mismatch

In Practice with Dr. Denver: How can case-finding help close care gaps for people with Alpha-1 Antitrypsin Deficiency (A1ATD)?

Care gaps are present across the care pathway for A1ATD-related liver disease; it is significantly underdiagnosed, suffers from a lack of awareness, and currently there

Featured Article: Silent plight

Silent plight

Share:

Related Posts

In Practice with Dr. Denver: How does case-finding address unmet needs in Primary Biliary Cholangitis?

The problem with liver trial bias, and how smart design can improve access.

In Practice with Dr. Denver: How can case-finding help close care gaps for people with Alpha-1 Antitrypsin Deficiency (A1ATD)?

Predictive Health Intelligence

Subscribe